S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
S&P 500   3,841.47 (-0.30%)
DOW   30,996.98 (-0.57%)
QQQ   325.42 (-0.29%)
AAPL   139.07 (+1.61%)
MSFT   225.95 (+0.44%)
FB   274.50 (+0.60%)
GOOGL   1,892.56 (+0.45%)
AMZN   3,292.23 (-0.45%)
TSLA   846.64 (+0.20%)
NVDA   548.50 (-1.12%)
BABA   258.62 (-0.53%)
CGC   33.80 (+0.72%)
GE   11.11 (+0.36%)
MU   82.28 (-3.21%)
AMD   92.79 (+1.38%)
NIO   61.95 (+6.19%)
T   28.93 (+0.35%)
F   11.52 (-0.09%)
ACB   10.65 (-4.66%)
BA   205.84 (-0.76%)
DIS   172.78 (+0.88%)
NFLX   565.17 (-2.53%)
GILD   66.94 (-0.06%)
Log in
NASDAQ:XPER

Xperi Competitors

$21.83
+0.22 (+1.02 %)
(As of 01/22/2021 12:00 AM ET)
Add
Compare
Today's Range
$21.22
Now: $21.83
$21.87
50-Day Range
$18.97
MA: $20.67
$21.90
52-Week Range
$9.01
Now: $21.83
$22.09
Volume355,397 shs
Average Volume486,222 shs
Market Capitalization$2.31 billion
P/E RatioN/A
Dividend Yield0.93%
Beta0.36

Competitors

Xperi (NASDAQ:XPER) Vs. AMAT, LRCX, KLAC, ENTG, MKSI, and BRKS

Should you be buying XPER stock or one of its competitors? Companies in the sub-industry of "semiconductor equipment" are considered alternatives and competitors to Xperi, including Applied Materials (AMAT), Lam Research (LRCX), KLA (KLAC), Entegris (ENTG), MKS Instruments (MKSI), and Brooks Automation (BRKS).

Xperi (NASDAQ:XPER) and Applied Materials (NASDAQ:AMAT) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Valuation & Earnings

This table compares Xperi and Applied Materials' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xperi$280.07 million8.24$-62,530,000.00$2.568.53
Applied Materials$17.20 billion5.65$3.62 billion$4.1725.50

Applied Materials has higher revenue and earnings than Xperi. Xperi is trading at a lower price-to-earnings ratio than Applied Materials, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Xperi and Applied Materials, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Xperi00503.00
Applied Materials051702.77

Xperi currently has a consensus price target of $26.50, suggesting a potential upside of 21.39%. Applied Materials has a consensus price target of $89.1304, suggesting a potential downside of 16.18%. Given Xperi's stronger consensus rating and higher possible upside, equities analysts plainly believe Xperi is more favorable than Applied Materials.

Profitability

This table compares Xperi and Applied Materials' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Xperi-8.65%18.37%9.41%
Applied Materials21.04%40.65%18.07%

Insider and Institutional Ownership

86.2% of Xperi shares are held by institutional investors. Comparatively, 78.8% of Applied Materials shares are held by institutional investors. 1.8% of Xperi shares are held by insiders. Comparatively, 0.4% of Applied Materials shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Dividends

Xperi pays an annual dividend of $0.20 per share and has a dividend yield of 0.9%. Applied Materials pays an annual dividend of $0.88 per share and has a dividend yield of 0.8%. Xperi pays out 7.8% of its earnings in the form of a dividend. Applied Materials pays out 21.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Applied Materials has raised its dividend for 3 consecutive years. Xperi is clearly the better dividend stock, given its higher yield and lower payout ratio.

Volatility & Risk

Xperi has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Applied Materials has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500.

Summary

Applied Materials beats Xperi on 10 of the 17 factors compared between the two stocks.

Xperi (NASDAQ:XPER) and Lam Research (NASDAQ:LRCX) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Valuation & Earnings

This table compares Xperi and Lam Research's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xperi$280.07 million8.24$-62,530,000.00$2.568.53
Lam Research$10.04 billion8.08$2.25 billion$15.9535.35

Lam Research has higher revenue and earnings than Xperi. Xperi is trading at a lower price-to-earnings ratio than Lam Research, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Xperi and Lam Research, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Xperi00503.00
Lam Research042102.84

Xperi currently has a consensus price target of $26.50, suggesting a potential upside of 21.39%. Lam Research has a consensus price target of $417.40, suggesting a potential downside of 25.97%. Given Xperi's stronger consensus rating and higher possible upside, equities analysts plainly believe Xperi is more favorable than Lam Research.

Profitability

This table compares Xperi and Lam Research's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Xperi-8.65%18.37%9.41%
Lam Research23.60%55.82%20.06%

Insider and Institutional Ownership

86.2% of Xperi shares are held by institutional investors. Comparatively, 84.0% of Lam Research shares are held by institutional investors. 1.8% of Xperi shares are held by insiders. Comparatively, 0.3% of Lam Research shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Dividends

Xperi pays an annual dividend of $0.20 per share and has a dividend yield of 0.9%. Lam Research pays an annual dividend of $5.20 per share and has a dividend yield of 0.9%. Xperi pays out 7.8% of its earnings in the form of a dividend. Lam Research pays out 32.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Lam Research has raised its dividend for 3 consecutive years. Lam Research is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Volatility & Risk

Xperi has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Lam Research has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

Summary

Lam Research beats Xperi on 11 of the 17 factors compared between the two stocks.

Xperi (NASDAQ:XPER) and KLA (NASDAQ:KLAC) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Valuation & Earnings

This table compares Xperi and KLA's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xperi$280.07 million8.24$-62,530,000.00$2.568.53
KLA$5.81 billion8.11$1.22 billion$10.3529.47

KLA has higher revenue and earnings than Xperi. Xperi is trading at a lower price-to-earnings ratio than KLA, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Xperi and KLA, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Xperi00503.00
KLA071102.61

Xperi currently has a consensus price target of $26.50, suggesting a potential upside of 21.39%. KLA has a consensus price target of $233.6667, suggesting a potential downside of 23.39%. Given Xperi's stronger consensus rating and higher possible upside, equities analysts plainly believe Xperi is more favorable than KLA.

Profitability

This table compares Xperi and KLA's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Xperi-8.65%18.37%9.41%
KLA21.76%65.49%18.66%

Insider and Institutional Ownership

86.2% of Xperi shares are held by institutional investors. Comparatively, 88.7% of KLA shares are held by institutional investors. 1.8% of Xperi shares are held by insiders. Comparatively, 0.2% of KLA shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Dividends

Xperi pays an annual dividend of $0.20 per share and has a dividend yield of 0.9%. KLA pays an annual dividend of $3.60 per share and has a dividend yield of 1.2%. Xperi pays out 7.8% of its earnings in the form of a dividend. KLA pays out 34.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. KLA has raised its dividend for 10 consecutive years. KLA is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Volatility & Risk

Xperi has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, KLA has a beta of 1.26, meaning that its stock price is 26% more volatile than the S&P 500.

Summary

KLA beats Xperi on 12 of the 17 factors compared between the two stocks.

Xperi (NASDAQ:XPER) and Entegris (NASDAQ:ENTG) are both business services companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Valuation & Earnings

This table compares Xperi and Entegris' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xperi$280.07 million8.24$-62,530,000.00$2.568.53
Entegris$1.59 billion9.53$254.86 million$1.9358.20

Entegris has higher revenue and earnings than Xperi. Xperi is trading at a lower price-to-earnings ratio than Entegris, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings and target prices for Xperi and Entegris, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Xperi00503.00
Entegris02502.71

Xperi currently has a consensus price target of $26.50, suggesting a potential upside of 21.39%. Entegris has a consensus price target of $89.5556, suggesting a potential downside of 20.27%. Given Xperi's stronger consensus rating and higher possible upside, equities analysts plainly believe Xperi is more favorable than Entegris.

Profitability

This table compares Xperi and Entegris' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Xperi-8.65%18.37%9.41%
Entegris15.03%26.54%12.06%

Insider and Institutional Ownership

86.2% of Xperi shares are held by institutional investors. Comparatively, 98.4% of Entegris shares are held by institutional investors. 1.8% of Xperi shares are held by insiders. Comparatively, 1.7% of Entegris shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Dividends

Xperi pays an annual dividend of $0.20 per share and has a dividend yield of 0.9%. Entegris pays an annual dividend of $0.32 per share and has a dividend yield of 0.3%. Xperi pays out 7.8% of its earnings in the form of a dividend. Entegris pays out 16.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Entegris has raised its dividend for 1 consecutive years. Xperi is clearly the better dividend stock, given its higher yield and lower payout ratio.

Volatility & Risk

Xperi has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Entegris has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500.

Summary

Entegris beats Xperi on 10 of the 16 factors compared between the two stocks.

Xperi (NASDAQ:XPER) and MKS Instruments (NASDAQ:MKSI) are both business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Institutional and Insider Ownership

86.2% of Xperi shares are owned by institutional investors. Comparatively, 94.0% of MKS Instruments shares are owned by institutional investors. 1.8% of Xperi shares are owned by insiders. Comparatively, 1.1% of MKS Instruments shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Dividends

Xperi pays an annual dividend of $0.20 per share and has a dividend yield of 0.9%. MKS Instruments pays an annual dividend of $0.80 per share and has a dividend yield of 0.4%. Xperi pays out 7.8% of its earnings in the form of a dividend. MKS Instruments pays out 17.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Xperi is clearly the better dividend stock, given its higher yield and lower payout ratio.

Valuation and Earnings

This table compares Xperi and MKS Instruments' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xperi$280.07 million8.24$-62,530,000.00$2.568.53
MKS Instruments$1.90 billion5.37$140.39 million$4.5240.93

MKS Instruments has higher revenue and earnings than Xperi. Xperi is trading at a lower price-to-earnings ratio than MKS Instruments, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Xperi and MKS Instruments, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Xperi00503.00
MKS Instruments02902.82

Xperi currently has a consensus price target of $26.50, suggesting a potential upside of 21.39%. MKS Instruments has a consensus price target of $162.70, suggesting a potential downside of 12.05%. Given Xperi's stronger consensus rating and higher possible upside, research analysts clearly believe Xperi is more favorable than MKS Instruments.

Profitability

This table compares Xperi and MKS Instruments' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Xperi-8.65%18.37%9.41%
MKS Instruments12.78%16.49%9.74%

Risk and Volatility

Xperi has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, MKS Instruments has a beta of 1.6, suggesting that its stock price is 60% more volatile than the S&P 500.

Summary

MKS Instruments beats Xperi on 9 of the 16 factors compared between the two stocks.

Xperi (NASDAQ:XPER) and Brooks Automation (NASDAQ:BRKS) are both mid-cap business services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

Institutional and Insider Ownership

86.2% of Xperi shares are owned by institutional investors. Comparatively, 95.3% of Brooks Automation shares are owned by institutional investors. 1.8% of Xperi shares are owned by insiders. Comparatively, 1.6% of Brooks Automation shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Dividends

Xperi pays an annual dividend of $0.20 per share and has a dividend yield of 0.9%. Brooks Automation pays an annual dividend of $0.40 per share and has a dividend yield of 0.5%. Xperi pays out 7.8% of its earnings in the form of a dividend. Brooks Automation pays out 31.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Xperi is clearly the better dividend stock, given its higher yield and lower payout ratio.

Valuation and Earnings

This table compares Xperi and Brooks Automation's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Xperi$280.07 million8.24$-62,530,000.00$2.568.53
Brooks Automation$897.27 million6.98$64.85 million$1.2667.00

Brooks Automation has higher revenue and earnings than Xperi. Xperi is trading at a lower price-to-earnings ratio than Brooks Automation, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Xperi and Brooks Automation, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Xperi00503.00
Brooks Automation02602.75

Xperi currently has a consensus price target of $26.50, suggesting a potential upside of 21.39%. Brooks Automation has a consensus price target of $64.8750, suggesting a potential downside of 23.15%. Given Xperi's stronger consensus rating and higher possible upside, research analysts clearly believe Xperi is more favorable than Brooks Automation.

Profitability

This table compares Xperi and Brooks Automation's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Xperi-8.65%18.37%9.41%
Brooks Automation7.23%7.95%6.13%

Risk and Volatility

Xperi has a beta of 0.36, suggesting that its stock price is 64% less volatile than the S&P 500. Comparatively, Brooks Automation has a beta of 1.97, suggesting that its stock price is 97% more volatile than the S&P 500.

Summary

Xperi beats Brooks Automation on 9 of the 16 factors compared between the two stocks.


Xperi Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Applied Materials logo
AMAT
Applied Materials
2.1$106.33+1.5%$97.22 billion$17.20 billion27.13
Lam Research logo
LRCX
Lam Research
2.2$563.85+0.1%$81.20 billion$10.04 billion31.98Upcoming Earnings
KLA logo
KLAC
KLA
2.2$305.01+0.1%$47.11 billion$5.81 billion37.11
Entegris logo
ENTG
Entegris
2.0$112.33+1.1%$15.16 billion$1.59 billion57.61Analyst Downgrade
MKS Instruments logo
MKSI
MKS Instruments
2.3$185.00+0.0%$10.20 billion$1.90 billion36.93Upcoming Earnings
Analyst Upgrade
Brooks Automation logo
BRKS
Brooks Automation
2.1$84.42+0.3%$6.26 billion$897.27 million95.93
CMC Materials logo
CCMP
CMC Materials
1.8$167.54+0.2%$4.88 billion$1.12 billion34.69Analyst Downgrade
Advanced Energy Industries logo
AEIS
Advanced Energy Industries
1.7$118.83+1.1%$4.55 billion$788.95 million44.01
Amkor Technology logo
AMKR
Amkor Technology
1.9$18.47+0.1%$4.48 billion$4.05 billion14.43
FormFactor logo
FORM
FormFactor
1.6$49.29+1.9%$3.81 billion$589.46 million49.79
Onto Innovation logo
ONTO
Onto Innovation
1.5$57.79+1.2%$2.82 billion$305.90 million-304.16
Cohu logo
COHU
Cohu
1.5$48.36+0.3%$2.03 billion$583.33 million-43.57
Ultra Clean logo
UCTT
Ultra Clean
1.5$43.36+0.1%$1.76 billion$1.07 billion40.15Analyst Revision
Axcelis Technologies logo
ACLS
Axcelis Technologies
1.7$40.09+0.4%$1.34 billion$342.96 million30.14Analyst Report
Gap Up
Veeco Instruments logo
VECO
Veeco Instruments
1.4$20.68+0.2%$1.03 billion$419.35 million-24.05
PDF Solutions logo
PDFS
PDF Solutions
1.4$22.35+0.1%$818.68 million$85.58 million-89.40Analyst Downgrade
Photronics logo
PLAB
Photronics
1.7$11.92+1.8%$761.88 million$609.69 million22.49Insider Selling
AXT logo
AXTI
AXT
1.3$11.94+0.4%$493.12 million$83.26 million-397.87
Rubicon Technology logo
RBCN
Rubicon Technology
0.5$9.85+0.1%$23.85 million$3.53 million-41.03
This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.